Background: The epithelial layer of the nasal mucosa is the first
barrier for drug permeation during intranasal drug delivery. With
increasing interest for intranasal pathways, adequate in vitro models
are required. Here, porcine olfactory (OEPC) and respiratory (REPC)
primary cells were characterised against the nasal tumour cell line RPMI
2650. Methods: Culture conditions for primary cells from porcine nasal
mucosa were optimized and the cells characterised via light microscope,
RT-PCR and immunofluorescence. Epithelial barrier function was analysed
via transepithelial electrical resistance (TEER), and FITC-dextran was
used as model substance for transepithelial permeation. Beating cilia
necessary for mucociliary clearance were studied by immunoreactivity
against acetylated tubulin. Results: OEPC and REPC barrier models differ
in TEER, transepithelial permeation and MUC5AC levels. In contrast, RPMI
2650 displayed lower levels of MUC5AC, cilia markers and TEER, and
higher FITC-dextran flux rates. Conclusion: To screen pharmaceutical
formulations for intranasal delivery in vitro, translational mucosal
models are needed. Here, a novel and comprehensive characterisation of
OEPC and REPC against RPMI 2650 is presented. The established primary
models display an appropriate model for nasal mucosa with secreted
MUC5AC, beating cilia and a functional epithelial barrier, which is
suitable for long-term evaluation of sustained release dosage forms.
«
Background: The epithelial layer of the nasal mucosa is the first
barrier for drug permeation during intranasal drug delivery. With
increasing interest for intranasal pathways, adequate in vitro models
are required. Here, porcine olfactory (OEPC) and respiratory (REPC)
primary cells were characterised against the nasal tumour cell line RPMI
2650. Methods: Culture conditions for primary cells from porcine nasal
mucosa were optimized and the cells characterised via light microscope,
RT-PCR and imm...
»